研究人员发现JAK抑制剂可能治愈有毒的上皮瘤内分泌,这是一种致命的皮肤疾病。 Researchers find JAK inhibitors may cure toxic epidermal necrolysis, a deadly skin disease.

澳大利亚和德国的研究人员开发了一种潜在的治疗方法,治疗有毒的上皮瘤内分泌(TEN),这是一种罕见的、威胁生命的皮肤疾病,导致严重发泡和皮肤分解。 Researchers from Australia and Germany have developed a potential cure for toxic epidermal necrolysis (TEN), a rare, life-threatening skin disease that causes severe blistering and skin detachment. 通常由药物反应引发,TEN死亡率为30%。 Often triggered by medication reactions, TEN has a 30% mortality rate. 视察队利用JAK抑制剂成功地治疗了7名病人,导致全面康复。 The team used JAK inhibitors to successfully treat seven patients, leading to full recovery. 该研究发表在《自然》杂志上,可导致对JAK抑制剂进行临床试验,作为TEN的治疗方法。 The study, published in Nature, could lead to clinical trials for JAK inhibitors as a cure for TEN.